Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Epidermal growth factor receptor peptide vaccination induces cross-reactive immunity to human EGFR, HER2, and HER3.

Doyle HA, Koski RA, Bonafé N, Bruck RA, Tagliatela SM, Gee RJ, Mamula MJ.

Cancer Immunol Immunother. 2018 Oct;67(10):1559-1569. doi: 10.1007/s00262-018-2218-9. Epub 2018 Jul 28.

PMID:
30056598
2.

Structural and biochemical analyses of alanine racemase from the multidrug-resistant Clostridium difficile strain 630.

Asojo OA, Nelson SK, Mootien S, Lee Y, Rezende WC, Hyman DA, Matsumoto MM, Reiling S, Kelleher A, Ledizet M, Koski RA, Anthony KG.

Acta Crystallogr D Biol Crystallogr. 2014 Jul;70(Pt 7):1922-33. doi: 10.1107/S1399004714009419. Epub 2014 Jun 29.

3.

Characterization of Ixophilin, a thrombin inhibitor from the gut of Ixodes scapularis.

Narasimhan S, Perez O, Mootien S, DePonte K, Koski RA, Fikrig E, Ledizet M.

PLoS One. 2013 Jul 9;8(7):e68012. doi: 10.1371/journal.pone.0068012. Print 2013.

4.

Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones.

Lee Y, Mootien S, Shoen C, Destefano M, Cirillo P, Asojo OA, Yeung KR, Ledizet M, Cynamon MH, Aristoff PA, Koski RA, Kaplan PA, Anthony KG.

Biochem Pharmacol. 2013 Jul 15;86(2):222-30. doi: 10.1016/j.bcp.2013.05.004. Epub 2013 May 13.

5.

Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signaling.

Sultana H, Neelakanta G, Foellmer HG, Montgomery RR, Anderson JF, Koski RA, Medzhitov RM, Fikrig E.

J Immunol. 2012 Sep 15;189(6):3150-8. doi: 10.4049/jimmunol.1201140. Epub 2012 Aug 15.

6.

A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF).

Bai F, Asojo OA, Cirillo P, Ciustea M, Ledizet M, Aristoff PA, Leng L, Koski RA, Powell TJ, Bucala R, Anthony KG.

J Biol Chem. 2012 Aug 31;287(36):30653-63. doi: 10.1074/jbc.M112.385583. Epub 2012 Jul 10.

7.

Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus.

Ciustea M, Mootien S, Rosato AE, Perez O, Cirillo P, Yeung KR, Ledizet M, Cynamon MH, Aristoff PA, Koski RA, Kaplan PA, Anthony KG.

Biochem Pharmacol. 2012 Feb 1;83(3):368-77. doi: 10.1016/j.bcp.2011.11.021. Epub 2011 Nov 29.

8.

Structural studies of human glioma pathogenesis-related protein 1.

Asojo OA, Koski RA, Bonafé N.

Acta Crystallogr D Biol Crystallogr. 2011 Oct;67(Pt 10):847-55. doi: 10.1107/S0907444911028198. Epub 2011 Sep 8.

9.

New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis.

Anthony KG, Strych U, Yeung KR, Shoen CS, Perez O, Krause KL, Cynamon MH, Aristoff PA, Koski RA.

PLoS One. 2011;6(5):e20374. doi: 10.1371/journal.pone.0020374. Epub 2011 May 26.

10.

Expression, purification, crystallization and preliminary X-ray analysis of a truncated soluble domain of human glioma pathogenesis-related protein 1.

Bonafé N, Zhan B, Bottazzi ME, Perez OA, Koski RA, Asojo OA.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Nov 1;66(Pt 11):1487-9. doi: 10.1107/S1744309110035669. Epub 2010 Oct 28.

11.

Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.

Sultana H, Foellmer HG, Neelakanta G, Oliphant T, Engle M, Ledizet M, Krishnan MN, Bonafé N, Anthony KG, Marasco WA, Kaplan P, Montgomery RR, Diamond MS, Koski RA, Fikrig E.

J Immunol. 2009 Jul 1;183(1):650-60. doi: 10.4049/jimmunol.0900093. Epub 2009 Jun 17.

12.

Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome.

Anthony KG, Bai F, Krishnan MN, Fikrig E, Koski RA.

Antiviral Res. 2009 Jun;82(3):166-8. doi: 10.1016/j.antiviral.2008.12.007. Epub 2009 Jan 7.

PMID:
19135091
13.

A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.

Bonafé N, Rininger JA, Chubet RG, Foellmer HG, Fader S, Anderson JF, Bushmich SL, Anthony K, Ledizet M, Fikrig E, Koski RA, Kaplan P.

Vaccine. 2009 Jan 7;27(2):213-22. doi: 10.1016/j.vaccine.2008.10.046. Epub 2008 Nov 7.

14.

Serum antibodies to West Nile virus in naturally exposed and vaccinated horses.

Magnarelli LA, Bushmich SL, Anderson JF, Ledizet M, Koski RA.

J Med Microbiol. 2008 Sep;57(Pt 9):1087-93. doi: 10.1099/jmm.0.47849-0.

15.

RNA interference screen for human genes associated with West Nile virus infection.

Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, Brass AL, Adametz R, Tsui M, Qian F, Montgomery RR, Lev S, Mason PW, Koski RA, Elledge SJ, Xavier RJ, Agaisse H, Fikrig E.

Nature. 2008 Sep 11;455(7210):242-5. doi: 10.1038/nature07207.

16.

Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.

Ledizet M, Kar K, Foellmer HG, Bonafé N, Anthony KG, Gould LH, Bushmich SL, Fikrig E, Koski RA.

J Infect Dis. 2007 Dec 15;196(12):1741-8. doi: 10.1086/523654.

PMID:
18190253
17.

A tick antioxidant facilitates the Lyme disease agent's successful migration from the mammalian host to the arthropod vector.

Narasimhan S, Sukumaran B, Bozdogan U, Thomas V, Liang X, DePonte K, Marcantonio N, Koski RA, Anderson JF, Kantor F, Fikrig E.

Cell Host Microbe. 2007 Jul 12;2(1):7-18.

18.

Antiviral peptides targeting the west nile virus envelope protein.

Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.

J Virol. 2007 Feb;81(4):2047-55. Epub 2006 Dec 6.

19.

Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity.

Doyle HA, Zhou J, Wolff MJ, Harvey BP, Roman RM, Gee RJ, Koski RA, Mamula MJ.

J Biol Chem. 2006 Oct 27;281(43):32676-83. Epub 2006 Sep 1.

20.

Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

Kanai R, Kar K, Anthony K, Gould LH, Ledizet M, Fikrig E, Marasco WA, Koski RA, Modis Y.

J Virol. 2006 Nov;80(22):11000-8. Epub 2006 Aug 30.

21.

Detection of antibodies to West Nile virus in equine sera using microsphere immunoassay.

Balasuriya UB, Shi PY, Wong SJ, Demarest VL, Gardner IA, Hullinger PJ, Ferraro GL, Boone JD, De Cino CL, Glaser AL, Renshaw RW, Ledizet M, Koski RA, MacLachlan NJ.

J Vet Diagn Invest. 2006 Jul;18(4):392-5.

PMID:
16921881
22.
23.

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus.

Gould LH, Sui J, Foellmer H, Oliphant T, Wang T, Ledizet M, Murakami A, Noonan K, Lambeth C, Kar K, Anderson JF, de Silva AM, Diamond MS, Koski RA, Marasco WA, Fikrig E.

J Virol. 2005 Dec;79(23):14606-13.

24.

The Lyme disease agent exploits a tick protein to infect the mammalian host.

Ramamoorthi N, Narasimhan S, Pal U, Bao F, Yang XF, Fish D, Anguita J, Norgard MV, Kantor FS, Anderson JF, Koski RA, Fikrig E.

Nature. 2005 Jul 28;436(7050):573-7.

25.

A recombinant envelope protein vaccine against West Nile virus.

Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, Fikrig E, Koski RA.

Vaccine. 2005 Jun 10;23(30):3915-24. Epub 2005 Apr 6.

PMID:
15917113
26.

Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay.

Wong SJ, Demarest VL, Boyle RH, Wang T, Ledizet M, Kar K, Kramer LD, Fikrig E, Koski RA.

J Clin Microbiol. 2004 Jan;42(1):65-72.

27.

Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination.

Wong SJ, Boyle RH, Demarest VL, Woodmansee AN, Kramer LD, Li H, Drebot M, Koski RA, Fikrig E, Martin DA, Shi PY.

J Clin Microbiol. 2003 Sep;41(9):4217-23.

28.

A novel family of anticoagulants from the saliva of Ixodes scapularis.

Narasimhan S, Koski RA, Beaulieu B, Anderson JF, Ramamoorthi N, Kantor F, Cappello M, Fikrig E.

Insect Mol Biol. 2002 Dec;11(6):641-50.

PMID:
12421422
29.

Examination of the Borrelia burgdorferi transcriptome in Ixodes scapularis during feeding.

Narasimhan S, Santiago F, Koski RA, Brei B, Anderson JF, Fish D, Fikrig E.

J Bacteriol. 2002 Jun;184(11):3122-5.

30.

West Nile virus envelope protein: role in diagnosis and immunity.

Wang T, Anderson JF, Magnarelli LA, Bushmich S, Wong S, Koski RA, Fikrig E.

Ann N Y Acad Sci. 2001 Dec;951:325-7.

PMID:
11797789
31.

Immunization of mice against West Nile virus with recombinant envelope protein.

Wang T, Anderson JF, Magnarelli LA, Wong SJ, Koski RA, Fikrig E.

J Immunol. 2001 Nov 1;167(9):5273-7.

32.

Hookworm burden reductions in BALB/c mice vaccinated with recombinant Ancylostoma secreted proteins (ASPs) from Ancylostoma duodenale, Ancylostoma caninum and Necator americanus.

Sen L, Ghosh K, Bin Z, Qiang S, Thompson MG, Hawdon JM, Koski RA, Shuhua X, Hotez PJ.

Vaccine. 2000 Jan 6;18(11-12):1096-102.

PMID:
10590331
33.

Experimental approaches to the development of a recombinant hookworm vaccine.

Hotez PJ, Ghosh K, Hawdon JM, Narasimhan S, Jones B, Shuhua X, Sen L, Bin Z, Haechou X, Hainan R, Heng W, Koski RA.

Immunol Rev. 1999 Oct;171:163-71. Review.

PMID:
10582170
34.

Activation of the Axl receptor tyrosine kinase induces mitogenesis and transformation in 32D cells.

McCloskey P, Pierce J, Koski RA, Varnum B, Liu ET.

Cell Growth Differ. 1994 Oct;5(10):1105-17.

35.

Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family.

Silbiger SM, Jacobsen VL, Cupples RL, Koski RA.

Gene. 1994 Apr 20;141(2):293-7.

PMID:
8163205
36.

Synthesis, degradation, and subcellular localization of proteins encoded by the primary response genes TIS7/PC4 and TIS21/PC3.

Varnum BC, Reddy ST, Koski RA, Herschman HR.

J Cell Physiol. 1994 Jan;158(1):205-13.

PMID:
8263025
37.

Cytokines in inflammatory malignant fibrous histiocytoma presenting with leukemoid reaction.

Melhem MF, Meisler AI, Saito R, Finley GG, Hockman HR, Koski RA.

Blood. 1993 Oct 1;82(7):2038-44.

PMID:
7691245
38.

Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma.

Finley GG, Koski RA, Melhem MF, Pipas JM, Meisler AI.

Cancer Res. 1993 Jun 15;53(12):2919-26.

39.

Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.

Melhem MF, Meisler AI, Finley GG, Bryce WH, Jones MO, Tribby II, Pipas JM, Koski RA.

Cancer Res. 1992 Nov 1;52(21):5853-64.

40.

Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.

Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y.

Cell. 1992 Apr 3;69(1):205-16.

PMID:
1348215
41.

Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters.

Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA, Herschman HR.

J Biol Chem. 1991 Aug 5;266(22):14511-8.

42.

Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals.

Cao XM, Koski RA, Gashler A, McKiernan M, Morris CF, Gaffney R, Hay RV, Sukhatme VP.

Mol Cell Biol. 1990 May;10(5):1931-9.

43.

Controlled expression and purification of human immune interferon from high-cell-density fermentations of Saccharomyces cerevisiae.

Fieschko JC, Egan KM, Ritch T, Koski RA, Jones M, Bitter GA.

Biotechnol Bioeng. 1987 Jun;29(9):1113-21.

PMID:
18576565
44.

Expression and secretion vectors for yeast.

Bitter GA, Egan KM, Koski RA, Jones MO, Elliott SG, Giffin JC.

Methods Enzymol. 1987;153:516-44. No abstract available.

PMID:
2828848
46.

Fossils of hydrothermal vent worms from cretaceous sulfide ores of the samail ophiolite, oman.

Haymon RM, Koski RA, Sinclair C.

Science. 1984 Mar 30;223(4643):1407-9.

PMID:
17746052
47.
48.
49.

Mutations of the yeast SUP4 tRNATyr locus: transcription of the mutant genes in vitro.

Koski RA, Clarkson SG, Kurjan J, Hall BD, Smith M.

Cell. 1980 Nov;22(2 Pt 2):415-25.

PMID:
7004643
50.

Delimitation of a promoter for RNA polymerase III by means of a functional test.

Telford JL, Kressmann A, Koski RA, Grosschedl R, Müller F, Clarkson SG, Birnstiel ML.

Proc Natl Acad Sci U S A. 1979 Jun;76(6):2590-4.

Supplemental Content

Loading ...
Support Center